Arcus Biosciences director awarded stock and options
Arcus Biosciences director Patrick Machado received new equity awards.
Rhea-AI Filing Summary
Arcus Biosciences director Patrick Machado received new equity awards. On June 11, 2026 he was granted 5,700 shares of common stock in the form of restricted stock units, which vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders, and become fully vested if the Company undergoes a change in control.
He was also granted stock options for 16,900 shares at an exercise price of $23.30 per share, expiring on June 10, 2036, with the same vesting and change‑in‑control acceleration terms. Following these awards, Machado directly holds 44,300 shares of Arcus Biosciences common stock. These are compensation-related grants rather than open‑market purchases.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 22,600 shares
Grant/Award
2 txns
Insider
Machado Patrick
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 16,900 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 16,900 contracts (Direct);
Common Stock — 44,300 shares (Direct)
Footnotes (2)
- F1. Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- F2. The option will vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.
Key Figures
RSU grant: 5,700 shares
Option grant size: 16,900 shares
Option exercise price: $23.30 per share
+2 more
5 metrics
RSU grant
5,700 shares
Restricted stock units granted on June 11, 2026
Option grant size
16,900 shares
Stock options granted on June 11, 2026
Option exercise price
$23.30 per share
Stock option exercise price
Option expiration
June 10, 2036
Stock option expiration date
Shares held after grant
44,300 shares
Common stock directly held following grants
Key Terms
restricted stock units, change in control, stock option, annual meeting of stockholders
4 terms
restricted stock units financial
"Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
change in control financial
"The RSUs will become fully vested in the event the Company is subject to a change in control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
stock option financial
"The option will vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
annual meeting of stockholders financial
"vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Arcus Biosciences (RCUS) disclose for Patrick Machado?
Arcus Biosciences reported that director Patrick Machado received equity compensation. He was granted 5,700 restricted stock units and stock options for 16,900 shares on June 11, 2026, both vesting by June 11, 2027 or at the next annual stockholder meeting.
How many restricted stock units did Patrick Machado receive from Arcus Biosciences (RCUS)?
Patrick Machado received 5,700 restricted stock units from Arcus Biosciences. These RSUs vest in full on the earlier of June 11, 2027 or the next annual stockholder meeting and fully vest if the company experiences a change in control event.
What are the details of the stock options granted to Patrick Machado by Arcus Biosciences (RCUS)?
Machado was granted stock options for 16,900 shares at an exercise price of $23.30 per share. The options vest fully on the earlier of June 11, 2027 or the next annual meeting and become fully exercisable if Arcus Biosciences undergoes a change in control.
When do Patrick Machado’s new Arcus Biosciences (RCUS) equity awards vest?
Both the 5,700 restricted stock units and the 16,900-share stock option grant vest in full on the earlier of June 11, 2027 or the next annual stockholder meeting. They also fully vest or become exercisable if the company is subject to a change in control.
AI-generated analysis. How Rhea-AI works. Not financial advice.
